Publication Name	World Journal of Diabetes
Manuscript ID	11683
Country	Ukraine

Received	2014-05-30 08:47
Peer-Review Started	2014-05-30 19:57
To Make the First Decision	2014-07-10 17:22
Return for Revision	2014-07-11 16:15
Revised	2014-07-16 11:18
Second Decision	2014-09-24 16:07
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-09-24 16:20
Articles in Press	2014-09-24 16:20
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-10-14 16:26
Publish the Manuscript Online	2014-12-13 19:01

ISSN	1948-9358 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Review
Article Title	Diabetes mellitus and cellular replacement therapy: Expected clinical potential and perspectives
Manuscript Source	Invited Manuscript
All Author List	Alexander E Berezin
Funding Agency and Grant Number
Corresponding Author	Alexander E Berezin, MD, PhD, Professor, Chief of Cardiology Unit, Department of Internal Medicine, State Medical University, 26, Mayakovsky av., 69035 Zaporozhye, Ukraine. dr_berezin@mail.ru
Key Words	Diabetes mellitus; Regenerative medicine; Stem cells; Cellular reprogramming; Transplantation
Core Tip	Modern approaches to stem cell therapy are discussed a promising component of treatment program in diabetes mellitus. It is important to emphasize that the new technology that is associated with reprogramming of stem cells has a couple of disputes in accordance with the ethical considerations and practical issues. However, the extremely high cost of novel methods toward preventing immune rejection of graft tissue and the high risk of oncogenesis retain their value as major constraints to the implementation into routine clinical practice. The purpose of the review was to summarize and analyze data for existing knowledge and prospects for future researches in the field of regenerative therapy in patients with diabetes mellitus.
Publish Date	2014-12-13 19:01
Citation	Berezin AE. Diabetes mellitus and cellular replacement therapy: Expected clinical potential and perspectives. World J Diabetes 2014; 5(6): 777-786
URL	http://www.wjgnet.com/1948-9358/full/v5/i6/777.htm
DOI	http://dx.doi.org/10.4239/wjd.v5.i6.777

Full Article (PDF)	WJD-5-777.pdf
Full Article (Word)	WJD-5-777.doc
Manuscript File	11683-Review.doc
Answering Reviewers	11683-Answering reviewers.pdf
Copyright License Agreement	11683-Copyright assignment.pdf
Peer-review Report	11683-Peer review(s).pdf
Scientific Misconduct Check	11683-CrossCheck.jpg
Scientific Editor Work List	11683-Scientific editor work list.pdf